UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933							OMB APPROVAL
							OMB Number: 3235-0101 Expires: December 31, 2006 Estimated average burden hours per response. . . . . . 4.47
							SEC USE ONLY
							DOCUMENT SEQUENCE NO.
ATTENTION:	Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker.						CUSIP NUMBER
1 (a) NAME OF ISSUER (Please type or print) West Pharmaceutical Services, Inc.		(b) IRS IDENT. NO. 23-1210010			(c) S.E.C. FILE NO. 1-8036		WORK LOCATION
1 (d) ADDRESS OF ISSUER STREET CITY STATE ZIP CODE 101 Gordon Drive, P.O. Box 645 Lionville PA 19341							(e) TELEPHONE NO.
							AREA CODE 610	NUMBER 593-2900
2 (a) NAME OF PERSON FOR WHOSE ACCOUNT THE SECURITIES ARE TO BE SOLD Donald E. Morel, Jr.			(b) IRS IDENT. NO.	(c) RELATIONSHIP TO ISSUER Officer and Director		(d) ADDRESS STREET CITY STATE ZIP CODE 101 Gordon Drive Lionville PA 19341

INSTRUCTION: The person filing this notice should contact the issuer to obtain the I.R.S. Identification Number and the S.E.C. File Number.

3 (a)	(b)	SEC USE ONLY	(c)	(d)	(e)	(f)	(g)
Title of the Class of Securities To Be Sold	Name and Address of Each Broker Through Whom the Securities are to be Offered or Each Market Maker who is Acquiring the Securities	Broker-Dealer File Number	Number of Shares or Other Units To Be Sold (See instr. 3(c)	Aggregate Market Value (See instr. 3(d)	Number of Shares or Other Units Outstanding (See instr. 3(e)	Approximate Date of Sale (See instr. 3(f (MO. DAY YR.)	Name of Each Securities Exchange (See instr. 3(g)
Common Stock	Citigroup/Smith Barney 100 Light Street Baltimore, MD 21202		2,000	96,298	32,409,315	11/08/2006	NYSE
Common Stock	Computer Investor Services 525 Washington Boulevard Jersey City, NJ 07310		3,000	144,447	32,409,315	11/09/2006	NYSE

INSTRUCTIONS:

1.	(a)	Name of issuer	3.	(a)	Title of the class of securities to be sold
	(b)	Issuer’s I.R.S. Identification Number		(b)	Name and address of each broker through whom the securities are intended to be sold
	(c)	Issuer’s S.E.C. file number, if any		(c)	Number of shares or other units to be sold (if debt securities, give the aggregate face amount)
	(d)	Issuer’s address, including zip code		(d)	Aggregate market value of the securities to be sold as of a specified date within 10 days prior to the filing of this notice
	(e)	Issuer’s telephone number, including area code		(e)	Number of shares or other units of the class outstanding, or if debt securities the face amount thereof outstanding, as shown by the most recent report or statement published by the issuer
				(f)	Approximate date on which the securities are to be sold
2.	(a)	Name of person for whose account the securities are to be sold		(g)	Name of each securities exchange, if any, on which the securities are intended to be sold
	(b)	Such person’s I.R.S. identification number, if such person is an entity
	(c)	Such person’s relationship to the issuer (e.g., officer, director, 10% stockholder, or member of immediate family of any of the foregoing)
	(d)	Such person’s address, including zip code

Potential persons who are to respond to the collection of information contained in this form are not

required to respond unless the form displays a currently valid OMB control number.

SEC 1147 (01-04)

TABLE I –– SECURITIES TO BE SOLD

Furnish the following information with respect to the acquisition of the securities to be sold
and with respect to the payment of all or any part of the purchase price or other consideration therefor:

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired (If gift, also give date donor acquired)	Amount of Securities Acquired	Date of Payment	Nature of Payment
Common Stock	9/12/06	Option Exercise	West Pharmaceutical Services	2,000	9/12/06	Delivery of previously-owned shares

INSTRUCTIONS:

If the securities were purchased and full payment therefor was not made in cash at
the time of purchase, explain in the table or in a note thereto the nature of the
consideration given. If the consideration consisted of any note or other obligation,
or if payment was made in installments describe the arrangement and state when
the note or other obligation was discharged in full or the last installment paid.

TABLE II –– SECURITIES SOLD DURING THE PAST 3 MONTHS

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Donald E. Morel, Jr. 101 Gordon Drive Lionville, PA 19341	Common Stock	8/31/06	5,000	196,350

REMARKS:

(1) Close price of 8/30/2006 ($39.27).

The notice shall be signed by the person for whose account the securities are to be sold. At least one copy of the notice shall be manually signed.
Any copies not manually signed shall bear typed or printed signatures.

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

SEC 1147 (01-04)

INSTRUCTIONS:

ATTENTION:

See the definition of “person” in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed.

/s/ Donald E. Morel, Jr.

DATE OF NOTICE

(SIGNATURE)